Skip to main content

Aindo

Aindo makes synthetic patient data for healthcare research. Its generative AI produces artificial cohorts that keep the statistical patterns of real patient records without exposing personal information, so studies can start in days rather than months. Pharmaceutical companies, hospitals and public bodies use it to generate real-world evidence and build synthetic control arms for clinical trials.

Traction 10/10
Trieste, Italy · HQ
Founded 2018387K+ followers
  • Healthcare Technology
  • Artificial Intelligence
  • Data & Analytics
  • Software Only
Updated today

Funding

Raised to date

$9.7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Daniele Panfilo

CEO

Product

Problem

Healthcare organizations hold patient records that could answer important research questions, but privacy rules and consent limits block access, and sharing the data with outside teams risks compliance breaches. Studies wait months for usable datasets.

Solution

Aindo's synthetic data platform uses generative AI to create artificial patient cohorts that mirror the statistical properties of real populations without containing identifiable information. Researchers can start analysis immediately, and the data can be shared across organizations without exposing patient-level records. The synthetic cohorts are clean and structured, ready for observational studies, outcomes research and Real World Evidence generation. For clinical trials, validated synthetic control arms can complement or replace traditional control groups, cutting recruitment needs and operational complexity. Aindo also offers specialized clinical language models trained on real and synthetic data to support treatment comparison and medical reasoning.

Target Audience

Pharmaceutical companies, contract research organizations, hospitals, researchers and public health institutions that need clinical evidence from patient data.

Features

  • Generate synthetic patient cohorts that reflect real populations and are ready for analysis.
  • Run observational studies and Real World Evidence generation without exposing identifiable data.
  • Build synthetic control arms to complement or replace traditional control groups in trials.
  • Share insights across organizations without sharing patient-level records.
  • Use clinical language models for treatment comparison and medical reasoning.
  • Deploy with compliance certifications including Europrivacy, ISO 27001 and AI Act alignment.
This profile is AI-generated and may contain inaccuracies.